{"news_desk": "Business", "print_page": "4", "section_name": "Business Day", "subsection_name": null, "byline": {"contributor": "", "original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "abstract": "New York State Atty Gen Eric T Schneiderman starts investigation into Turing Pharmaceuticals, which skyrocketed price of infection drug, causing backlash against high pharmaceutical prices; Schneiderman's office has addressed letter of inquiry directly to Turing head Martin Shkreli. ", "type_of_material": "News", "word_count": "785", "lead_paragraph": "Eric T. Schneiderman has begun an inquiry into whether Turing Pharmaceuticals violated antitrust rules by restricting distribution of a drug, Daraprim, as a way to thwart generic competition.", "pub_date": "2015-10-13T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "New York Attorney General Examining Whether Turing Restricted Drug Access", "print_headline": "New York Attorney General Examining if Turing Restricted Drug Access"}, "snippet": "Eric T. Schneiderman has begun an inquiry into whether Turing Pharmaceuticals violated antitrust rules by restricting distribution of a drug, Daraprim, as a way to thwart generic competition.", "multimedia": [{"height": 126, "url": "images/2015/10/13/business/13drug-web1/13drug-web1-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/10/13/business/13drug-web1/13drug-web1-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2015/10/13/business/13drug-web1/13drug-web1-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2015/10/13/business/13drug-web1/13drug-web1-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/10/13/business/13drug-web1/13drug-web1-thumbStandard-v4.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/10/13/business/13drug-web1/13drug-web1-thumbStandard-v4.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/10/13/business/new-york-attorney-general-examining-if-turing-restricted-drug-access.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Turing Pharmaceuticals AG", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "New York State", "name": "glocations"}, {"rank": "4", "is_major": "Y", "value": "Schneiderman, Eric T", "name": "persons"}, {"rank": "5", "is_major": "Y", "value": "Shkreli, Martin (1983- )", "name": "persons"}, {"rank": "6", "is_major": "N", "value": "Prices (Fares, Fees and Rates)", "name": "subject"}], "blog": [], "_id": "561c538238f0d84d2f3b8ac8", "source": "The New York Times"}